Completed OBSERVATIONAL NCT01206933

The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System

The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System.

Sponsor: George Washington University

Conditions Hepatitis C, Chronic Human Immunodeficiency Virus (HIV)

Updated 7 times since 2017 Last updated: Feb 8, 2016 Started: Jul 31, 2010 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hepatitis C, Chronic and Human Immunodeficiency Virus (HIV) and is currently completed. George Washington University leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

George Washington University

Data source: George Washington University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Washington D.C., United States